Serious and potentially deadly side effects have been linked to the numbing agent benzocaine used by dentists and also sold over the counter to relieve oral pain such as baby teething and canker sores.
The U.S. Food and Drug Administration reported in April 2011 that use of benzocaine in products such as Anbesol, Orajel, Baby Orajel, Orabase, Hurricaine and other store-brand gels and liquids as well as sprays Cetacaine, Exactacain, and Topex can cause methemoglobinemia, a blood-related ailment that can be fatal.
Hundreds of cases have been reported with most occurring in children two years old or younger whose parents administered benzocaine gel for teething, according to an April 2011 warning issued by the U.S. Food and Drug Administration (FDA).
If you, your baby or a loved one suffered serious illness or death as a suspected use of a benzocaine product, you should contact a benzocaine lawyer for a free evaluation of your case. Kline & Specter, PC, with more than 35 attorneys, several of whom are also doctors, is among the leading law firms in the nation to investigate and litigate potential benzocaine cases. We are available 24/7. Cases reviewed within 24 hours.
Symptoms of methemoglobinemia include gray or blue colored skin, lips, and nail beds and also headaches, lightheadedness, shortness of breath, fatigue and rapid heart rate.
Benzocaine is used by physicians in medical procedures to numb the mucous membranes in the mouth and throat. Over-the-counter products are used for a variety of ailments, including teething in babies, canker sores and to relieve pain due to irritation of the mouth and gums.
The FDA advised that benzocaine products not be used for children younger than two years old except under the advice and supervision of a health care professional. It said benzocaine products should be stored out of the reach of children.
Kline & Specter, PC works on a contingent fee basis, which means we only get paid if and when you are financially compensated. Contact a benzocaine attorney today.
Learn more about methemoglobinemia from the National Center for Biotechnology Information
